Black Women and Menopause: Disparities, Differences, and Finding Care

Menopause is universal. Every woman who lives long enough will go through it. But the experience of menopause — when it starts, how severe the symptoms are, how it's treated, and whether you can find a doctor who actually listens — is not the same for everyone. For Black women in America, menopause comes earlier, hits harder, lasts longer, and is treated less often. These aren't opinions. They're facts, documented in some of the largest and longest-running studies on women's health.

If you're a Black woman navigating perimenopause or menopause, this article is for you. Not to tell you what you already know about being dismissed or overlooked, but to arm you with the data that validates your experience and to help you find care that actually meets you where you are.

What the SWAN study revealed

The Study of Women's Health Across the Nation (SWAN) is the gold standard when it comes to understanding how menopause affects different populations of women. Launched in 1996, SWAN followed over 3,300 women from five racial and ethnic groups — White, Black, Chinese, Japanese, and Hispanic — through the menopausal transition for more than 20 years. It's the most comprehensive longitudinal study of menopause ever conducted, and its findings on racial disparities are stark.

Here is what SWAN documented about Black women's experience of menopause:

• Earlier onset: Black women in the SWAN cohort entered perimenopause a median of 8.5 years before their final menstrual period, compared to 6.5 years for White women. They also reached menopause approximately 2 years earlier on average.
• Longer duration of symptoms: Black women experienced vasomotor symptoms (hot flashes and night sweats) for a median of 10.1 years — the longest of any racial or ethnic group. White women averaged 6.5 years. That's almost four additional years of debilitating symptoms.
• Greater severity: Black women reported the most frequent and most severe hot flashes of any group studied. These weren't minor inconveniences — they disrupted sleep, work productivity, and daily functioning.
• More sleep disturbance: Black women in SWAN reported significantly more sleep difficulties, including insomnia and frequent nighttime waking, which compounded the effects of other symptoms.

These aren't small differences. A woman who experiences severe hot flashes for 10 years has a fundamentally different quality of life during midlife than a woman whose symptoms last 6 years. And those years overlap with some of the most demanding periods of a woman's professional and personal life.

Why the differences exist

Researchers have identified several factors that contribute to these disparities, and it's important to understand that they are complex and interconnected — rooted in both biology and the social determinants of health.

Biological factors

There are measurable biological differences in how hormones fluctuate during the menopausal transition across racial groups. Black women in the SWAN study had different patterns of estradiol and follicle-stimulating hormone (FSH) changes compared to White women. Some researchers have hypothesized that differences in body composition, vitamin D metabolism, and inflammatory markers may influence symptom severity, though the mechanisms are not fully understood.

Black women also have higher rates of uterine fibroids — affecting up to 80% of Black women by age 50, compared to about 70% of White women — which can lead to heavier, more irregular periods during perimenopause and increase the likelihood of hysterectomy, which brings its own set of hormonal consequences.

Stress, racism, and weathering

The concept of "weathering" — the theory that chronic exposure to racial discrimination and systemic stress accelerates biological aging — is highly relevant to menopause. Research by Dr. Arline Geronimus and others has shown that the cumulative burden of racism affects cellular aging, inflammation, and hormonal regulation. Black women carry a disproportionate allostatic load (the biological "wear and tear" of chronic stress), which may contribute to earlier menopause onset and more severe symptoms.

This isn't about individual stress management. It's about the health toll of navigating a society where systemic racism is a daily reality — from workplace discrimination to healthcare bias to the stress of code-switching to the weight of being strong for everyone else.

Healthcare access and treatment disparities

Even when Black women seek care for menopausal symptoms, they are significantly less likely to receive treatment. The data here is unambiguous:

• Black women are less likely to be prescribed HRT than White women, even when they report the same symptoms at the same severity levels. A 2023 analysis of prescribing patterns found that Black women were approximately 50% less likely to receive a menopause-related prescription after a primary care visit than White women.
• Black women are more likely to have their symptoms attributed to stress, weight, or lifestyle factors rather than recognized as hormonal — a pattern of diagnostic bias well-documented across many areas of medicine.
• The STRIDE study (Strategies for Prescribing Exercise in Depression), while focused on depression treatment, revealed broader patterns relevant to menopause care: Black women were less likely to be referred to specialists and more likely to receive generalized lifestyle advice rather than targeted treatment.
• Black women are underrepresented in menopause clinical trials, which means the evidence base for treatment efficacy and safety is less applicable to them.

The provider problem

Finding a menopause specialist is already difficult for any woman in the U.S. — only about 1,300 physicians hold NCMP (NAMS Certified Menopause Practitioner) certification nationwide. For Black women, there's an additional layer: finding a provider who is culturally competent and understands how menopause may present differently.

Cultural competence in menopause care means more than being polite. It means:

• Understanding that Black women may experience more severe and longer-lasting vasomotor symptoms and adjusting treatment expectations accordingly
• Not dismissing symptoms as weight-related without doing a proper hormonal evaluation
• Recognizing the higher prevalence of fibroids and how they interact with menopause symptoms and HRT decisions
• Being aware of the historical reasons Black women may distrust the medical system — from the Tuskegee syphilis study to the experimentation of J. Marion Sims to ongoing disparities in maternal mortality
• Creating a clinical environment where Black women feel heard, believed, and respected

The shortage of Black physicians compounds this challenge. Black doctors represent approximately 5% of the physician workforce while Black people make up about 13% of the population. Research consistently shows that racial concordance between patient and provider leads to better communication, higher trust, and improved health outcomes.

HRT safety considerations for Black women

One of the most damaging consequences of the menopause care gap is that Black women have been disproportionately denied the benefits of HRT while facing disproportionately severe symptoms.

It's worth noting: the WHI study that led to 20 years of fear about HRT actually included a significant number of Black women — about 16% of the study population. The reanalysis of WHI data has shown that the same general safety profile applies across racial groups when HRT is initiated within the timing window (within 10 years of menopause onset or before age 60).

Some specific considerations for Black women and HRT:

• Cardiovascular health: Black women have higher rates of hypertension, which is a consideration for HRT. However, transdermal estrogen (patches, gels) does not significantly affect blood pressure and is generally considered safe for women with controlled hypertension. Your provider should evaluate your individual cardiovascular risk, not deny treatment based on population-level statistics.
• Fibroids: Estrogen can stimulate fibroid growth, which is a consideration for women with large or symptomatic fibroids. However, this is a treatment planning issue, not a contraindication. Providers experienced in menopause care can manage HRT safely in women with fibroids.
• Blood clot risk: Transdermal estrogen avoids the first-pass liver effect that increases clotting risk with oral estrogen. For women with elevated cardiovascular risk factors, transdermal delivery is the preferred route.
• Bone health: Black women generally have higher bone mineral density than White women, but they still experience bone loss during menopause. HRT provides bone-protective benefits across all racial groups.

Finding culturally competent menopause care

If you're a Black woman looking for a provider who will take your menopause symptoms seriously and provide appropriate care, here are strategies that other women have found helpful:

• Look for NCMP-certified providers — these physicians have dedicated training in menopause medicine and are more likely to offer evidence-based HRT
• Ask directly about their experience treating Black patients — a provider who is comfortable with this question is more likely to provide culturally competent care
• Seek out Black menopause specialists and advocacy organizations — groups like the Black Women's Health Imperative and The Balm in Gilead provide resources and provider recommendations
• Consider telehealth options — platforms like Midi Health and Alloy Health expand geographic access and may offer providers from diverse backgrounds
• Bring your data — track your symptoms (frequency, severity, duration) for at least 2 to 4 weeks before your appointment. Objective data makes it harder for symptoms to be dismissed
• Request hormone level testing — while menopause is primarily diagnosed by symptoms, lab work can help confirm where you are in the transition and guide treatment decisions

You deserve the same quality of care

The disparities in menopause care for Black women are real, documented, and unacceptable. They reflect broader patterns of inequity in American healthcare that require systemic change — more diverse clinical trials, more menopause training in medical education, more cultural competency requirements, and more accountability for diagnostic bias.

But systemic change takes time, and you need care now. You deserve a provider who takes your symptoms seriously, who understands the data on racial differences in menopause, who offers evidence-based treatment including HRT when appropriate, and who treats you as a whole person — not a set of risk factors.

Your symptoms are real. Your experience is valid. And effective treatment exists. The challenge is finding the right provider, and that's a challenge worth taking on.

This article is for informational purposes only and does not constitute medical advice. It is not a substitute for professional medical evaluation, diagnosis, or treatment. Always consult with a qualified healthcare provider about your individual health needs.